Early-stage development

Transforming bold ideas into viable clinical plans.

Key Services

We help medtech innovators navigate the critical early phases of development, offering integrated strategies that align with regulatory expectations, market needs, and patient realities.

Clinical strategies that ensure safety, effectiveness, and performance meet both regulatory standards and real-world needs
Clinical strategies that ensure safety, effectiveness, and performance meet both regulatory standards and real-world needs
Clinical strategies that ensure safety, effectiveness, and performance meet both regulatory standards and real-world needs
Evidence-based plans that balance scientific rigor with patient-centered design to support approval and adoption
Evidence-based plans that balance scientific rigor with patient-centered design to support approval and adoption
Evidence-based plans that balance scientific rigor with patient-centered design to support approval and adoption
Clinical gap analysis and due diligence to support fundraising, partnerships, or M&A readiness
Clinical gap analysis and due diligence to support fundraising, partnerships, or M&A readiness
Clinical gap analysis and due diligence to support fundraising, partnerships, or M&A readiness

Our Approach

  • Identify study designs aligned with global regulatory requirements and forecast timelines, resources, and budgets

  • Select endpoints and safety measures aligned with HTA and regulatory goals, integrating KOL and investigator input

  • Review protocols and evidence packages, identify gaps, and advise on remediation strategies during diligence processes